The impact of the COVID-19 surge after the end of China's Zero-COVID policy on the health-related quality of life of IBD patients.

ABSTRACT:

Introduction

In December 2019, COVID-19 emerged in Wuhan, Hubei Province, China, and rapidly spread worldwide. On December 2022, the Chinese government ended the zero-COVID policy, leading to a surge in cases and significantly impacting daily life. IBD patients face heightened infection risks and substantial effects on their quality of life during the pandemic.

Methods

This cross-sectional study collected demographic, COVID-19-related, and HRQoL data from 224 IBD patients who had previously received treatment at Nanjing BenQ Medical Center. Participants completed an online survey between January 9, 2023, and January 23, 2023. The SIBDQ was used to assess HRQoL. Statistical analysis was performed using SPSS version 26.

Results

The study found that UC patients reported

SUBMITTER: Wang R 

PROVIDER: S-EPMC11406827 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature